Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1985-12-18
1988-07-19
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514282, 514408, 514409, 5142255, 5142258, A61K 3140, A61K 3144, A61K 3154
Patent
active
047585625
ABSTRACT:
A combination of drugs including a kappa opioid receptor agonist and a dopamine receptor blocker or dopamine receptor agonist provides a synergistic effect in inducing hypothermia and/or poikilothermia in humans and animals. Hypothermia as much as 10.degree. C. at an ambient temperature of 20.degree. C. is possible, with complete recovery and few, if any, side effects.
REFERENCES:
Chem. Abst., 85-153867t (1976).
Lahti et al., Properties of a Selective Kappa Agonist, U-50,488H, Life Sciences, vol. 31, pp. 2257-2260, 1982.
Vonvoigtlander et al. U-50,488: A Selective and Structurally Novel Non-Mu(Kappa) Opioid Agonist, The Journal of Pharmacology and Experimental Therapeutics, vol. 224, No. 1, pp. 7-12, 1983.
Piercey et al., U-50488 H, A Pure Kappa Receptor Agonist with Spinal Analgesic Loci in the Mouse, Life Sciences, vol. 31, pp. 1197-1200, 1982.
Lahti et al., [3H] U-69593 A highly Selective Ligand for the Opioid K Receptor, European Journal of Pharmacology, 109, pp. 281 to 284, 1985.
Vonvoigtlander et al., Kappa Opioid Analgesia is Dependent on Serotonergic Mechanisms, The Journal of Pharmacology and Experimental Therapeutics, vol. 231, No. 2, pp. 270 to 274, 1984.
Shemano and Nickerson, Effect of Ambient Temperature on Thermal Responses to Drugs, Can. J. Biochem. Physiol., 36, pp. 1243 to 1249, 1958.
Hoffman and Zarrow, Hypothermia in Rat, Hamster, Ground Squirrel and Pigeon Following Chlorpromazine, Am. J. Physiol., 193, pp. 547 to 552, 1958.
Kollias and Bullard, The Influence of Chlorpromazine on Physical and Chemical Mechanisms of Temperature Regulation in the Rat; J. Pharmacol. Exp. Ther., 145:373-381, 1964.
Kirkpatrick and Lomax, Temperature Changes Induced by Chlorpromazine and N-Methyl Chlorpromazine in the Rat, Neuropharmacology 10:61-66, 1971.
Feigenbaum and Yanai, Implications of Dopamine Agonist-Induced Hypothermia Following Increased Density of Dopamine Receptors in the Mouse, Neuropharmacology, vol. 24, No. 8, pp. 735 to 741, 1985.
Yamawaki et al., Dopaminergic and Serotonergic Mechanisms of Thermoregulation: Mediation of Thermal Effects of Apomorphine and Dopamine, The Journal of Pharmacology and Experimental Therapeutics, vol. 227, No. 2, pp. 383 to 388, 1983.
Boublik and Funder, Interaction of Dopamine Receptor Ligands with Subtypes of the Opiate Receptor, European Journal of Pharmacology, 107, pp. 11 to 16, 1985.
Cooper et al., Effects of Tifluadom on Food Consumption Compared with Chlordiazepoxide and Kappa Agonists in the Rat, Neuropharmacology, vol. 24, No. 9, pp. 877 to 883, 1985.
Adler Martin W.
Geller Ellen B.
Friedman Stanley J.
Temple University Of The Commonwealth System Of Higher Education
LandOfFree
Method for inducing hypothermia and/or poikilothermia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inducing hypothermia and/or poikilothermia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inducing hypothermia and/or poikilothermia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597369